TransMedics: Every Hero Becomes A Bore At Last

My last analysis on TransMedics Group, Inc. (NASDAQ: TMDX ) warned that the upcoming aircraft maintenance challenges and aviation operating expenses would shake investors' confidence at the end of this year. Unfortunately, this also coincided with poor revenue performanceFounder/former executive of private jet airline - 9 figure exit to PE platform. Current CEO of FlyVizor, an aviation business advisory firm and host of The VIP Seat, a weekly business aviation news show available on most streaming platforms ...